Skip to main content

Table 3 Analysis of demographic characteristics and bladder outcomes of women undergoing pelvic floor reconstructive surgery, stratified by hysterectomy status

From: Postoperative urinary retention after pelvic organ prolapse surgery: influence of peri-operative factors and trial of void protocol

 

Reconstructive surgery with previous hysterectomy

Reconstructive surgery with concomitant hysterectomy

Total

Sacrocolpopexy

Sacrospinous suspension

p value

Total

Uterosacral suspension

Sacrospinous suspension

p value

Total

308

105

(34.1%, 29.0–39.6%)

203

(65.9%, 60.4–71.0%)

 

364

228

(62.6%, 57.5–67.5%)

136

(37.4%, 32.5–42.5%)

 

Age (years)

Mean

(95%CI)

64.5

(63.3–65.7)

63.5

(61.8–65.3)

65.0

(63.5–66.6)

0.377

60.2

(59.1–61.4)

59.4

(57.9–60.9)

61.5

(59.9–63.2)

0.254

Median (IQR)

65

(57.5–72)

63

(57–71)

66

(58–73)

62

(53–69)

61

(51–68)

62

(55–69)

 

Length of stay (days)

Mean

(95%CI)

2.8

(0.5–5.1)

1.8

(1.4–2.1)

3.3

(0.0–6.9)

0.622

1.8

(1.6–2.0)

1.7

(1.5–1.9)

1.8

(1.6–2.1)

0.524

Median (IQR)

1

(1–2)

1

(1–2)

1

(1–2)

2

(1–2)

1

(1–2)

1

(1–2)

Number of voids to pass bladder protocol

Mean

(95%CI)

2.8

(2.5–3.0)

2.7

(2.4–3.0)

2.8

(2.4–3.1)

0.439

3.4

(3.1–3.7)

3.4

(3.0–3.9)

3.6

(3.1–4.1)

0.056

Median (IQR)

2

(2–3)

2

(2–3)

2

(2–3)

2

(2–4)

2

(2–4)

3

(2–4)

Patients who went home with a catheter

N

78

23

55

0.321

119

79

40

0.303

Proportion

(95%CI)

25.3% (20.8–30.5%)

21.9% (15.0–30.9%)

27.1% (21.4–33.6%)

32.7% (28.1–37.7%)

34.6% (28.7–41.1%)

29.4% (22.3–37.7%)

Elevated PVR after second void

N

146

50

96

0.896

223

137

86

0.551

Proportion (95%CI)

48.6% (42.0–53.2%)

48.1%

(38.2–58.1%)

47.3%

(40.3–54.4%)

61.3%

(56.1–66.2%)

60.1%

(53.4–66.5%)

63.2%

(54.5–71.3%)

Crude Odds Ratio (95%CI)

-

1.0

(0.6–1.7)

Reference

-

0.9

(0.6–1.4)

Reference

Elevated PVR after third void

N

116

39

77

0.941

189

120

69

0.726

Proportion (95%CI)

37.8%

(32.5–43.4%)

37.5%

(28.2–47.5%)

37.9%

(31.2–45.0%)

51.9%

(46.8–57.0%)

52.6%

(45.9–59.3%)

50.7%

(42.0–59.4%)

Crude Odds Ratio (95%CI)

-

0.98

(0.6–1.6)

Reference

-

1.1

(0.7–1.7)

Reference

  1. The uterosacral suspension group for those with previous hysterectomy and the sacrocolpopexy for those with concomitant hysterectomy were excluded because of small sample size. Some values may not add to 100% due to missing values